Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000211

EVP, Chf Clinical Develop Ofcr sold 19,658 shares at an average $60.81 ($1,195,421)

  • EVP, Chf Clinical Develop Ofcr acquired 19,658 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-03 Exercise or conversion : show line 1 in the form 10b5-1 +19,658 $53.77 $1,057,011 71,165 D
2025-09-03 Sale : show line 2 in the form 10b5-1 −12,455 $60.46 $753,039 58,710 D
2025-09-03 Sale : show line 3 in the form 10b5-1 −7,203 $61.42 $442,382 51,507 D
Open-market sales · 19,658 sh · avg $60.81 · $1,195,421

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-03 Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −19,658 0 D
Loading xslF345X05/edgardoc.xml…